ACCESSCNY INC
EIN: 15-0532247Syracuse, NYZIP: 13208
G23Z - Diseases, Disorders & Medical Disciplines501(c)(3)
Mission
ACCESSCNY OFFERS PERSONCENTERED SERVICES THAT EMPOWER INDIVIDUALS OF ALL AGES AND ABILITIES TO REACH THEIR FULL POTENTIAL AS PART OF OUR SHARED COMMUNITY. SERVICES ARE PROVIDED WITH DEDICATION, COMPASSION, INNOVATION, AND COMMITMENT. THE AGENCY SUPPORTS PEOPLE WITH DEVELOPMENTAL DISABILITIES, ACQUIRED BRAIN INJURIES (ABI) AND MENTAL HEALTH ISSUES.
Financials
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $57.2M | $0 | $33.6M |
| 2023 | $53.1M | $0 | $30.3M |
Compensation
2024
2023
Similar Organizations
UNITED CEREBRAL PALSY ASSOCIATION
$56.5M revenueHauppauge, NY
Similar sector (G)Very similar revenue ($56.5M vs $57.2M)Same state (New York)
THE MARK FOUNDATION FOR CANCER RESEARCH
$44.8M revenueNew York, NY
Similar sector (G)Similar revenue ($44.8M vs $57.2M)Same state (New York)
GAY MEN'S HEALTH CRISIS INC
$38.7M revenueNew York, NY
Similar sector (G)Comparable revenue ($38.7M vs $57.2M)Same state (New York)Similar median compensation ($145k vs $132k)
NATIONAL KIDNEY FOUNDATION INC
$46.7M revenueNew York, NY
Similar sector (G)Similar revenue ($46.7M vs $57.2M)Same state (New York)
$46.1M revenue
Similar sector (G)Similar revenue ($46.1M vs $57.2M)Same state (New York)
HOUSING WORKS HEALTH SERVICES III INC
$43.4M revenueBrooklyn, NY
Similar sector (G)Similar revenue ($43.4M vs $57.2M)Same state (New York)
UNITED CEREBRAL PALSY OF QUEENS
$37.8M revenueJamaica, NY
Similar sector (G)Comparable revenue ($37.8M vs $57.2M)Same state (New York)Comparable compensation levels
AIDS SERVICE CENTER OF LOWER
$38.1M revenueNew York, NY
Similar sector (G)Comparable revenue ($38.1M vs $57.2M)Same state (New York)Comparable compensation levels
Frontier Science & Technology Research
$31M revenueAmherst, NY
Similar sector (G)Comparable revenue ($31M vs $57.2M)Same state (New York)
$30M revenue
Similar sector (G)Comparable revenue ($30M vs $57.2M)Same state (New York)
Data from IRS Form 990 filings (2023-2024).